SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-06-006152
Filing Date
2006-06-16
Accepted
2006-06-16 14:19:02
Documents
2
Period of Report
2006-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PHARMAFRONTIERS CORP. 8-K a5171730.txt 8-K 4387
2 EXHIBIT 99.1 a5171730ex99_1.txt EX-99.1 4567
  Complete submission text file 0001157523-06-006152.txt   10849
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25513 | Film No.: 06909770
SIC: 2834 Pharmaceutical Preparations